Humanised anti-interleukin-18 antibody
US8133978B2 · kind B2 · utility
2Cited by
3References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 23, 2007 |
| Grant date | Mar 13, 2012 |
| Priority date | — |
| Expiry date | Jan 22, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention discloses humanised anti-IL-18 antibodies, methods of manufacture, and methods of treatment with said antibodies. Further disclosed are screening methods using for example surface plasmon resonance to identify antibodies with therapeutic potential.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.